| Primary |
| Type 2 Diabetes Mellitus |
100.0% |
|
|
| Secondary |
| Type 2 Diabetes Mellitus |
37.3% |
| Product Used For Unknown Indication |
21.4% |
| Drug Use For Unknown Indication |
13.8% |
| Cardiac Failure |
7.6% |
| Diabetes Mellitus |
5.1% |
| Hypertension |
2.5% |
| Cancer Pain |
1.8% |
| Erythrodermic Psoriasis |
1.4% |
| Pancreatic Carcinoma Metastatic |
1.1% |
| Arthritis Reactive |
0.7% |
| Coagulopathy |
0.7% |
| Cough |
0.7% |
| Gastritis |
0.7% |
| Glioma |
0.7% |
| Headache |
0.7% |
| Hyperphosphataemia |
0.7% |
| Hyperuricaemia |
0.7% |
| Infection |
0.7% |
| Oedema Peripheral |
0.7% |
| Pyrexia |
0.7% |
|
| Hypoglycaemia |
20.8% |
| Loss Of Consciousness |
13.2% |
| Syncope |
11.3% |
| Cardiac Failure |
5.7% |
| Angioedema |
3.8% |
| Head Injury |
3.8% |
| Hypoglycaemic Coma |
3.8% |
| Hyponatraemia |
3.8% |
| Hypotonia |
3.8% |
| Iron Deficiency Anaemia |
3.8% |
| Oesophageal Candidiasis |
3.8% |
| Pulmonary Oedema |
3.8% |
| Renal Failure Chronic |
3.8% |
| Unresponsive To Stimuli |
3.8% |
| Anaemia |
1.9% |
| Anxiety |
1.9% |
| Bicytopenia |
1.9% |
| Bifascicular Block |
1.9% |
| Cardiac Arrest |
1.9% |
| Diarrhoea |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.4% |
| Diabetes Mellitus |
10.1% |
| Hypertension |
9.6% |
| Drug Use For Unknown Indication |
8.9% |
| Atrial Fibrillation |
3.4% |
| Pain |
3.2% |
| Type 2 Diabetes Mellitus |
3.1% |
| Myocardial Ischaemia |
2.9% |
| Prophylaxis |
2.8% |
| Gastric Cancer |
1.9% |
| Depression |
1.7% |
| Back Pain |
1.6% |
| Hyperglycaemia |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Cardiac Failure Congestive |
1.4% |
| Rheumatoid Arthritis |
1.3% |
| Prophylaxis Against Transplant Rejection |
1.3% |
| Renal Failure Chronic |
1.2% |
| Type 1 Diabetes Mellitus |
1.1% |
| Dyslipidaemia |
1.0% |
|
| Rhabdomyolysis |
10.6% |
| Vomiting |
10.6% |
| Renal Failure Acute |
9.6% |
| Renal Failure |
7.3% |
| Angina Pectoris |
5.0% |
| Myalgia |
4.6% |
| Renal Impairment |
4.6% |
| Sepsis |
4.6% |
| Respiratory Failure |
4.1% |
| Thrombocytopenia |
4.1% |
| Urinary Tract Infection |
4.1% |
| Chest Pain |
3.7% |
| Liver Function Test Abnormal |
3.7% |
| Myocardial Infarction |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Death |
3.2% |
| Drug Interaction |
3.2% |
| Erectile Dysfunction |
3.2% |
| Hallucination |
3.2% |
| Hyperkalaemia |
3.2% |
|
| Interacting |
| Cardiac Failure |
37.5% |
| Type 2 Diabetes Mellitus |
37.5% |
| Hypertension |
6.3% |
| Hyperuricaemia |
6.3% |
| Hypothyroidism |
6.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.3% |
|
|
